SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001318738-21-000001
Filing Date
2021-08-13
Accepted
2021-08-13 11:52:43
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 2361
  Complete submission text file 0001318738-21-000001.txt   3821
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Issuer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUER WALL 54 HAMBURG 2M D-20354
Business Address
Striepe Thomas (Reporting) CIK: 0001318738 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-29233 | Film No.: 211170700